Menu
← Oncology Approval Tracker
FDA DECISION ·
Midostaurin capsules (first generic)
midostaurin · Teva Pharmaceuticals Development
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic of the referenced midostaurin capsules for adults with newly diagnosed FLT3-positive AML in the designated chemotherapy regimen, or with aggressive systemic mastocytosis, systemic mastocytosis with an associated hematologic neoplasm, or mast cell leukemia.
LAMPGEN ANALYSIS
Why it matters
This decision offers a generic option for established, distinct leukemia and mast-cell indications.
What research teams should watch
Confirm FLT3 status and chemotherapy phase in AML; keep disease-specific schedules and interaction checks separate.
PRIMARY RECORDS